Trials / Unknown
UnknownNCT04033107
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
Clinical Research of High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Zhongnan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is an open, prospective, single-arm, multi-cohort clinical study to evaluate the efficacy and safety of high-dose vitamin C combined with metformin in the treatment of malignant tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin C | Participants will receive intravenous Vitamin C injection (dose: 1.5g/kg, D1-3, every 2 weeks), treatment termination when the disease progress is confirmed. |
| DRUG | Metformin | Participants will orally take metformin 4g daily. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2019-07-25
- Last updated
- 2023-09-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04033107. Inclusion in this directory is not an endorsement.